Chronic Disease in the Community (CDCom) Program: Hypertension and non-communicable disease care by village health workers in rural Uganda.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
23
08
2020
accepted:
08
02
2021
entrez:
25
2
2021
pubmed:
26
2
2021
medline:
24
8
2021
Statut:
epublish
Résumé
Although hypertension, the largest modifiable risk factor in the global burden of disease, is prevalent in sub-Saharan Africa, rates of awareness and control are low. Since 2011 village health workers (VHWs) in Kisoro district, Uganda have been providing non-communicable disease (NCD) care as part of the Chronic Disease in the Community (CDCom) Program. The VHWs screen for hypertension and other NCDs as part of a door-to-door biannual health census, and, under the supervision of health professionals from the local district hospital, also serve as the primary providers at monthly village-based NCD clinics. We describe the operation of CDCom, a 10-year comprehensive program employing VHWs to screen and manage hypertension and other NCDs at a community level. Using program records we also report hypertension prevalence in the community, program costs, and results of a cost-saving strategy to address frequent medication stockouts. Of 4283 people ages 30-69 screened for hypertension, 22% had a blood pressure (BP) ≥140/90 and 5% had a BP ≥ 160/100. All 163 people with SBP ≥170 during door-to-door screening were referred for evaluation in CDCom, of which 91 (59%) had repeated BP ≥170 and were enrolled in treatment. Of 761 patients enrolled in CDCom, 413 patients are being treated for hypertension and 68% of these had their most recent blood pressure below the treatment target. We find: 1) The difference in hypertension prevalence between this rural, agricultural population and national rates mirrors a rural-urban divide in many countries in sub-Saharan Africa. 2) VHWs are able to not only screen patients for hypertension, but also to manage their disease in monthly village-based clinics. 3) Mid-level providers at a local district hospital NCD clinic and faculty from an academic center provide institutional support to VHWs, stream-line referrals for complicated patients and facilitate provider education at all levels of care. 4) Selective stepdown of medication doses for patients with controlled hypertension is a safe, cost-saving strategy that partially addresses frequent stockouts of government-supplied medications and patient inability to pay. 5) CDCom, free for village members, operates at a modest cost of 0.20 USD per villager per year. We expect that our data-informed analysis of the program will benefit other groups attempting to decentralize chronic disease care in rural communities of low-income regions worldwide.
Sections du résumé
BACKGROUND
Although hypertension, the largest modifiable risk factor in the global burden of disease, is prevalent in sub-Saharan Africa, rates of awareness and control are low. Since 2011 village health workers (VHWs) in Kisoro district, Uganda have been providing non-communicable disease (NCD) care as part of the Chronic Disease in the Community (CDCom) Program. The VHWs screen for hypertension and other NCDs as part of a door-to-door biannual health census, and, under the supervision of health professionals from the local district hospital, also serve as the primary providers at monthly village-based NCD clinics.
OBJECTIVE/METHODS
We describe the operation of CDCom, a 10-year comprehensive program employing VHWs to screen and manage hypertension and other NCDs at a community level. Using program records we also report hypertension prevalence in the community, program costs, and results of a cost-saving strategy to address frequent medication stockouts.
RESULTS/CONCLUSIONS
Of 4283 people ages 30-69 screened for hypertension, 22% had a blood pressure (BP) ≥140/90 and 5% had a BP ≥ 160/100. All 163 people with SBP ≥170 during door-to-door screening were referred for evaluation in CDCom, of which 91 (59%) had repeated BP ≥170 and were enrolled in treatment. Of 761 patients enrolled in CDCom, 413 patients are being treated for hypertension and 68% of these had their most recent blood pressure below the treatment target. We find: 1) The difference in hypertension prevalence between this rural, agricultural population and national rates mirrors a rural-urban divide in many countries in sub-Saharan Africa. 2) VHWs are able to not only screen patients for hypertension, but also to manage their disease in monthly village-based clinics. 3) Mid-level providers at a local district hospital NCD clinic and faculty from an academic center provide institutional support to VHWs, stream-line referrals for complicated patients and facilitate provider education at all levels of care. 4) Selective stepdown of medication doses for patients with controlled hypertension is a safe, cost-saving strategy that partially addresses frequent stockouts of government-supplied medications and patient inability to pay. 5) CDCom, free for village members, operates at a modest cost of 0.20 USD per villager per year. We expect that our data-informed analysis of the program will benefit other groups attempting to decentralize chronic disease care in rural communities of low-income regions worldwide.
Identifiants
pubmed: 33630935
doi: 10.1371/journal.pone.0247464
pii: PONE-D-20-26454
pmc: PMC7906377
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0247464Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
BMJ. 2003 Jun 28;326(7404):1427
pubmed: 12829555
JAMA. 2017 Sep 19;318(11):1016-1025
pubmed: 28975305
Cardiol Rev. 2016 Jan-Feb;24(1):30-40
pubmed: 26284525
Am J Cardiol. 1984 May 1;53(9):1304-7
pubmed: 6711432
PLoS One. 2020 Jun 5;15(6):e0234049
pubmed: 32502169
PLoS One. 2015 Nov 11;10(11):e0142312
pubmed: 26560131
Lancet Glob Health. 2015 Sep;3(9):e556-63
pubmed: 26187361
PLoS Med. 2020 Jan 2;17(1):e1002997
pubmed: 31895945
Global Health. 2014 Nov 19;10:77
pubmed: 25406738
JAMA Netw Open. 2019 Dec 2;2(12):e1916545
pubmed: 31790570
Lancet. 2015 Aug 22;386(9995):801-12
pubmed: 25832858
Trop Med Int Health. 2014 Apr;19(4):459-68
pubmed: 24495307
PLoS One. 2015 Sep 25;10(9):e0138991
pubmed: 26406462
Am J Prev Med. 2007 May;32(5):435-47
pubmed: 17478270
Hypertension. 2015 Feb;65(2):291-8
pubmed: 25385758
Am Heart J. 2019 Oct;216:9-19
pubmed: 31377568
PLoS One. 2014 Aug 14;9(8):e103754
pubmed: 25121789
JAMA. 1981 Dec 4;246(22):2593-6
pubmed: 7299986
BMC Public Health. 2014 Mar 10;14:240
pubmed: 24606986
BMC Cardiovasc Disord. 2013 Aug 02;13:54
pubmed: 23915151
Glob Heart. 2017 Sep;12(3):233-243.e6
pubmed: 27993594
Glob Heart. 2019 Dec;14(4):355-365
pubmed: 31523014
J Hypertens. 2011 Jul;29(7):1243-52
pubmed: 21540748
BMJ Glob Health. 2018 Feb 15;3(1):e000566
pubmed: 29527344
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
JAMA Intern Med. 2018 Dec 1;178(12):1626-1634
pubmed: 30383082
Ann Glob Health. 2019 Mar 21;85(1):
pubmed: 30924618
Trop Med Int Health. 2015 Oct;20(10):1385-95
pubmed: 26095069
Health Policy Plan. 2016 Mar 8;31(7):878-883
pubmed: 26962122
BMJ Open. 2014 Oct 16;4(10):e005983
pubmed: 25324324